Vical develops biopharmaceutical products for the prevention and treatment of chronic or life-threatening infectious diseases, based on our patented DNA delivery technologies and other therapeutic approaches.

RECENT NEWS

August 8, 2017 Vical Reports Second Quarter 2017 Financial and Operational Results
August 1, 2017 Vical Announces News Release and Conference Call Schedule for Second Quarter 2017 Financial Results

August 8, 2017
Vical Reports Second Quarter 2017 Financial and Operational Results

August 1, 2017
Vical Announces News Release and Conference Call Schedule for Second Quarter 2017 Financial Results

EVENTS & PRESENTATIONS

August 8, 2017 Vical Inc. 2Q17 Financial Results Conference Call View the Webcast
June 21, 2017 Vical Provides Company Update at the 2017 BIO International Convention View the Webcast

August 8, 2017
Vical Inc. 2Q17 Financial Results Conference Call

June 21, 2017
Vical Provides Company Update at the 2017 BIO International Convention

PRODUCT PIPELINE

CONNECT WITH US

RSS Feeds
Email Alerts
LinkedIn
Slideshare
StockTwits
Twitter
YouTube

Privacy Policy
Terms of Use
Site Map

P. 858 646 1100 10390 Pacific Center Court, San Diego, California 92121

This link to a non-Vical website is provided as a resource. Vical assumes no responsibility for content not provided by Vical, or for practices or standards of any non-Vical websites.